(Epi)transcriptomics in cardiovascular and neurological complications of COVID-19

J Mol Cell Cardiol Plus. 2022 Sep:1:100013. doi: 10.1016/j.jmccpl.2022.100013. Epub 2022 Jul 28.

Abstract

Although systemic inflammation and pulmonary complications increase the mortality rate in COVID-19, a broad spectrum of cardiovascular and neurological complications can also contribute to significant morbidity and mortality. The molecular mechanisms underlying cardiovascular and neurological complications during and after SARS-CoV-2 infection are incompletely understood. Recently reported perturbations of the epitranscriptome of COVID-19 patients indicate that mechanisms including those derived from RNA modifications and non-coding RNAs may play a contributing role in the pathogenesis of COVID-19. In this review paper, we gathered recently published studies investigating (epi)transcriptomic fluctuations upon SARS-CoV-2 infection, focusing on the brain-heart axis since neurological and cardiovascular events and their sequelae are of utmost prevalence and importance in this disease.

Keywords: Brain-heart axis; COVID-19; RNAs.

Publication types

  • Review